While mentally stimulating activities and life experiences can improve cognition in memory clinic patients, stress undermines this beneficial relationship. This is according to a new study from Karolinska Institutet published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.

Researchers have developed a new model in which steam cells can be rapidly converted into brain cells with protein structures characteristic of Parkinson’s disease. This will help researchers to study Parkinson’s unique and highly variable disease pathology in a petri dish.

Researchers at The University of Texas at Austin are making use of artificial intelligence and biosensors to develop drugs faster. They are currently utilizing AI and genetically modified bacteria to ferment the Alzheimer’s drug Galantamine.

Scientists have found out that exposure to Agent Orange, a well-known toxin with wide-ranging health effects, damages brain tissue similar to those found in early-stage Alzheimer’s disease.

Researchers have now revealed new compounds that are capable of offering the same benefits as exercise. This discovery could play a potential role in treating patients with muscle atrophy and other medical conditions.

Researchers have developed a new microscopy technology called decrowding expansion pathology (dexpath) which is capable of providing detailed images of brain cancer tissue. The potential technology can be used for gaining insights into brain cancer development as well as other aggressive neurological diseases.

Researchers are trying to investigate if improving oral health i.e. looking after teeth and gums could protect people from the dementia disease, an illness related to memory loss.

The National Research Foundation has funded 36 million dollars to the National University of Singapore’s Mechanobiology Institute for developing biomedical innovations for infertility, muscle loss and cancer.

Researchers at the Chalmers University of Technology have discovered a new method for capturing many proteins in nano-sized traps. With this method, proteins can be studied in a way that has not been possible before.

Scientists at the Alzheimer’s Center at Temple University have discovered a new potential therapeutic target for Alzheimer's disease: the ABCA7 protein. Research shows that this protein may have a protective effect against Alzheimer's